Interest Expense of Armata Pharmaceuticals, Inc. from 31 Mar 2013 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Armata Pharmaceuticals, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Mar 2013 to 30 Jun 2024.
  • Armata Pharmaceuticals, Inc. Interest Expense for the quarter ending 30 Jun 2024 was $2,718,000.
  • Armata Pharmaceuticals, Inc. annual Interest Expense for 2022 was $0, a 100% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Interest Expense for 2021 was $64,000, a 90% decline from 2020.
  • Armata Pharmaceuticals, Inc. annual Interest Expense for 2020 was $628,000, a 33% decline from 2019.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Armata Pharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $2,718,000 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,820,000 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 $1,176,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q4 2021 $64,000 $0 -$177,000 -100% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $241,000 $2,000 -$148,000 -99% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $389,000 $0 -$142,000 -100% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $531,000 $62,000 -$97,000 -61% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $628,000 $177,000 -$28,000 -14% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $656,000 $150,000 -$40,000 -21% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $696,000 $142,000 -$88,000 -38% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $784,000 $159,000 -$147,000 -48% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $931,000 $205,000 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $190,000 -$117,000 -38% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $230,000 -$51,000 -18% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $306,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q3 2018 $307,000 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $281,000 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2017 $7,000 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2014 $0 $0 $0 01 Oct 2014 31 Dec 2014 10-K 15 Apr 2015 2014 FY
Q3 2014 $0 $0 -$9,000 -100% 01 Jul 2014 30 Sep 2014 10-Q/A 15 Apr 2015 2014 Q3
Q2 2014 $9,000 $0 -$128,000 -100% 01 Apr 2014 30 Jun 2014 10-Q/A 15 Apr 2015 2014 Q2
Q1 2014 $137,000 $0 -$96,000 -100% 01 Jan 2014 31 Mar 2014 10-Q/A 15 Apr 2015 2014 Q1
Q4 2013 $233,000 $0 01 Oct 2013 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q3 2013 $9,000 01 Jul 2013 30 Sep 2013 10-Q/A 15 Apr 2015 2014 Q3
Q2 2013 $128,000 01 Apr 2013 30 Jun 2013 10-Q/A 15 Apr 2015 2014 Q2
Q1 2013 $96,000 01 Jan 2013 31 Mar 2013 10-Q/A 15 Apr 2015 2014 Q1

Armata Pharmaceuticals, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $0 -$64,000 -100% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 $64,000 -$564,000 -90% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $628,000 -$303,000 -33% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $931,000 -$82,000 -8.1% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
2018 $1,013,000 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
2016 $6,000 01 Jan 2016 31 Dec 2016 10-K 27 Mar 2017 2016 FY
2014 $0 -$233,000 -100% 01 Jan 2014 31 Dec 2014 10-K 15 Apr 2015 2014 FY
2013 $233,000 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.